Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-11

Clinical Trial Update: Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating estradiol transdermal spray for vasomotor symptoms (hot flashes) of menopause has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estradiol Transdermal Spray (estradiol transdermal spray)

Snippet

Sponsor: Lumara Health, Inc. | Conditions: Hot Flashes | Phase 3 | Status: COMPLETED | Results posted: 2012-06-11